Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

COVID-19 in persons with multiple sclerosis treated with ocrelizumab: pharmacovigilance update

Research Alert

Newswise — Background: Limited evidence-based data exist on potential risks of COVID-19 infection in persons with multiple sclerosis (pwMS) receiving immunotherapy. More than 160,000 pwMS have been treated with ocrelizumab (OCR), in clinical trial and real-world settings; data continue to show a consistent and favorable benefit/risk profile.

Objectives: To present a summary of postmarketing pharmacovigilance data (as of May 31, 2020) from pwMS treated with OCR, who have either confirmed or suspected COVID-19.

Methods: Pharmacovigilance-reported adverse event (AE) COVID-19 cases, identified in a search of the Roche Global Safety Database using MedDRA preferred terms and string searches, were defined as valid when at least an identifiable reporter, a single identifiable patient, a medicinal product and a suspected AE were provided. Cases were designated as serious if described by the reporter as serious according to their judgment or if adjudicated as serious by the company when regulatory definitions were met. Patient characteristics and details of OCR treatment were usually provided. All cases were conservatively considered as having confirmed COVID-19. Outcome was classified as recovered, recovering, not recovered, fatal, or not reported.

Results: Of 201 cases, 61% (n=122/201) were reported as non-serious, and 39% (n=79/201) were reported as serious, mostly due to hospitalization (n=51/79). Where known, reasons for hospitalization included, among others, treatment of pneumonia and treatment in ICU. Serious cases were reported as recovered/recovering in 32% (n=25/79) of patients, whilst the outcome was not reported in 33% (n=26/79) of serious cases. A fatal outcome was reported in 5.5% (n=11/201) of patients; risk factors included hypertension, diabetes mellitus, respiratory disease, and malignancy. Updated assessment of the pharmacovigilance cases will be presented.

Conclusions: Taking into account the known limitations of postmarketing safety data, this analysis appears to be in line with published larger case series of non-MS and MS COVID-19 patients. Risk factors in fatal cases were similar to known risk factors reported in the general population.

Presenter: Richard Hughes, F. Hoffmann-La Roche Ltd, , Grenzacherstrasse 124, N/A, Basel, CH




Filters close

Showing results

110 of 3798
Released: 28-Oct-2020 3:20 AM EDT
Risk score predicts prognosis of outpatients with COVID-19
Massachusetts General Hospital

A new artificial intelligence-based score considers multiple factors to predict the prognosis of individual patients with COVID-19 seen at urgent care clinics or emergency departments.

Released: 28-Oct-2020 1:10 AM EDT
Swiss fatalism protects against negative feelings in the pandemic
University of Zurich

Trust or disappointment in government crisis management is an important factor for the general mood, shows a study by the University of Zurich based on surveys in Israel and Switzerland.

Released: 28-Oct-2020 12:05 AM EDT
Low-cost airlines have adapted best to COVID-19
Universitat Oberta De Catalunya (UOC)

The COVID-19 pandemic has caused a dramatic reduction in travel, especially to other countries.

Newswise: Dermatologist Provides Skin Care to People Experiencing Homelessness Amid COVID-19
Released: 27-Oct-2020 5:05 PM EDT
Dermatologist Provides Skin Care to People Experiencing Homelessness Amid COVID-19
American Academy of Dermatology

The American Academy of Dermatology (AAD) named board-certified dermatologist Jennifer Tan, MD, FAAD, a Patient Care Hero for making critical skin care and hygiene items easily accessible to individuals experiencing homelessness during the COVID-19 pandemic.

Released: 27-Oct-2020 5:00 PM EDT
The fact that SARS-CoV-2 virus can or cannot spread through airborne transmission does not render masks "worthless"
Newswise

A video featuring Owen Shroyer originally published by Banned.video went viral on Facebook in late October. The video claims that the U.S. Centers for Disease Control and Prevention (CDC) confirmed SARS-CoV-2, the virus that causes COVID-19, was never airborne, and wearing face masks is unnecessary. This claim is false and inaccurate. The CDC never said the virus could not be airborne. Although the CDC "updated" their guidance on its website to include aerosols among the most common forms of SARS-CoV-2 transmission, experts agree that the virus can spread through water droplets, which masks can act as a physical barrier to stpp the water droplets. There is increasing evidence that suggest airborne transmission may also play a role in the spread of COVID-19.

Newswise: Neutrons chart atomic map of COVID-19’s viral replication mechanism
Released: 27-Oct-2020 3:40 PM EDT
Neutrons chart atomic map of COVID-19’s viral replication mechanism
Oak Ridge National Laboratory

To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction. Researchers at the Department of Energy’s Oak Ridge National Laboratory used neutron scattering to identify key information to improve the effectiveness of drug inhibitors designed to block the virus’s replication mechanism.

access_time Embargo lifts in 2 days
Embargo will expire: 28-Oct-2020 3:10 PM EDT Released to reporters: 27-Oct-2020 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Oct-2020 3:10 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 27-Oct-2020 12:05 PM EDT
Rush Preparing for COVID-19 Resurgence
Rush University Medical Center

With Chicago and Illinois seeing a surge in cases of COVID-19 and the city and state implementing new restrictions to lessen the spread of the disease, Rush University System for Health is preparing for a resurgence of cases. Rush will continue to diligently prepare and plan its response to the surge to ensure the safety of everyone in Rush hospitals and clinics and within the Rush community.

Released: 27-Oct-2020 11:55 AM EDT
Precaution: Lessons from COVID-19
Singapore University of Technology and Design

Which is more important in the initial phase of a pandemic: taking precautionary actions or responding to its severity? That is the question that researchers from the Singapore University of Technology and Design (SUTD) set out to address in an article published in BioEssays.


Showing results

110 of 3798

close
0.95641